Association of -1171 promoter polymorphism of matrix metalloproteinase-3 with increased risk for oral cancer

Anticancer Research

Volumn 27, Issue 6 B, 2007, Pages 4095-4100

  Vairaktaris, Eleftherios ^a   Yapijakis, Christos ^a   Vasiliou, Stavros ^a   Derka, Spyridoula ^a   Nkenke, Emeka ^b   Serefoglou, Zoe ^a   Vorris, Eleni ^a   Vylliotis, Antonis ^a   Ragos, Vasilios ^a   Neukam, Friedrich W ^b   Patsouris, Efstratios ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

Angiogenesis; Matrix metalloproteinase 3; Oral cancer; Polymorphism; Thrombophilia

Indexed keywords

STROMELYSIN;

ADULT; AGED; ALLELE; ARTICLE; CANCER RISK; CANCER STAGING; CONTROLLED STUDY; DISEASE ASSOCIATION; ETHNICITY; FAMILY HISTORY; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; HETEROZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; MOUTH CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; RESTRICTION MAPPING; SQUAMOUS CELL CARCINOMA; THROMBOPHILIA;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MATRIX METALLOPROTEINASE 3; MIDDLE AGED; MOUTH NEOPLASMS; POLYMORPHISM, GENETIC; PROMOTER REGIONS (GENETICS);

EID: 35349002682     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Hanahan D and Weinberg RA: The hallmarks of cancer. Cell 100: 57-70, 2000.
2. Vokes EE, Weichselbaum RR, Lippman SM and Hong WK: Head and neck cancer. N Engl J Med 328: 184-194, 1993.
3. Muscat JE and Wynder EL: Tobacco, alcohol, asbestos and occupational risk factors for laryngeal cancer. Cancer 69: 2244-2251, 1992.
4. Jefferies SA and Foulkes WD: Review. Genetic mechanisms in squamous cell carcinoma of the head and neck. Oral Oncol 37: 115-126, 2001.
5. Song C, Xing D, Tan W, Wei Q and Lin D: Methylenetetrahydrofolate reductase polymorphisms increase risk of esophageal squamous cell carcinoma in a Chinese population. Cancer Res 61: 3272-3275, 2001.
6. Vairaktaris E, Yapijakis C, Wiltfang JV, Ries J, Vylliotis A, Derka S, Vasiliou S and Neukam FW: Are factor V and prothrombin mutations associated with increased risk of oral cancer? Anticancer Res 25: 2561-2566, 2005.
7. Vairaktaris E, Yapijakis C, Kessler P, Vylliotis A, Ries J, Wiltfang J, Vassiliou S, Derka S and Neukam FW: Methylenetetrahydrofolate reductase polymorphism and minor increase of risk for oral cancer. J Cancer Res Clin Oncol 132: 219-222, 2006.
8. Vairaktaris E, Yapijakis C, Serefoglou Z, Vylliotis A, Ries J, Nkenke E, Wiltfang J, Derka S, Vassiliou S, Springer I, Kessler P and Neukman FW: Plasminogen activator inhibitor-1 polymorphism is associated with increased risk for oral cancer. Oral Oncol 42: 888-892, 2006.
9. Vairaktaris E, Yapijakis C, Derka S, Vassiliou S, Serefoglou Z, Vylliotis A, Wiltfang J, Springer I, Nkenke E, Kessler P and Neukam FW: Association of platelet glycoprotein Ia polymorphism with minor increase of risk for oral cancer. Eur J Surg Oncol 32: 455-457, 2006.
10. Galis ZS, Sukhova GK, Lark MW and Libby P: Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. J Clin Invest 94: 2493-2503, 1994.
11. Kerkelä E and Saarialho-Kere U: Review Article. Matrix metalloproteinases in tumor progression: focus on basal and squamous cell skin cancer. Exp Dermatol 12: 109-125, 2003.
12. Matrisian LM: Cancer biology: extracellular proteinases in malignancy. Curr Biol 9: 776-778, 1999.
13. Nagase H and Woessner JF: Matrix Metalloproteinases. J Biol Chem 274: 21491-21494, 1999.
14. Kahari VM and Saarialho-Kere U: Matrix metalloproteinases and their inhibitors in tumour growth and invasion. Ann Med 31: 34-45, 1999.
15. Sage EH, Reed M, Funk SE, Truong T, Steadele M, Puolakkainen P, Maurice DH and Bassuk JA: Cleavage of the matricellular protein SPARC by matrix metalloproteinase 3 produces polypeptides that influence angiogenesis. J Biol Chem 278: 37849-37857, 2003.
16. Johanssona N, Ahonenb M and Kähäri VM: Matrix metalloproteinases in tumor invasion. Cell Mol Life Sc 57: 5-15, 2000.
17. Fang S, Jin X, Wang R, Li Y, Guo W, Wang N, Wang Y, Wen D, Wei L and Zhang J: Polymorphisms in the MMP1 and MMP3 promoter and non-small cell lung carcinoma in North China. Carcinogenesis 26: 481-486, 2005.
18. Ylipalosaari M: Matrix metalloproteinases (MMPs) in oral carcinomas. Dissertation, Oulu University Press, Oulu 2005.
19. Thomas GT, Lewis MP and Speight PM: Matrix metalloproteinases and oral cancer. Oral Oncol 35: 227-233, 1999.
20. Ye S, Eriksson P, Hamsten A, Kurkinen M, Humphries SE and Henney AM: Progression of coronary atherosclerosis is associated with a common genetic variant of the human stromelysin-1 promoter which results in reduced gene expression, J Biol Chem 271: 13055-13060, 1996.
21. Ghilardi G, Biondi M L, Caputo M, Leviti S, Monti M and Guagnellini E: A single nucleotide polymorphism in the matrix metalloproteinase-promoter enhances breast cancer susceptibility. Clin Cancer Res 8: 3820-3823, 2002.
22. Lei H, Zaloudik J and Vorechovky I: Lack of association of the -1171 5A allele of the MMP3 promoter with breast cancer. Clin Chem 5: 798-799, 2002.
23. Dörr S, Lechtenböhmer N, Rau R, Herborn G, Wagner U, Müller-Myhsok B, Hansmann I and Keyszer G: Association of a specific haplotype across the genes MMP1 and MMP3 with radiographic joint destruction in rheumatoid arthritis. Arthritis Res Ther 6: 199-207, 2004.
24. Mora B, Bonamico M, Ferri M, Megiorni F, Osborn J, Pizzuti A and Mazzilli MC: Association of the matrix metalloproteinase-3 (MMP-3) promoter polymorphism with celiac disease in male subjects. Hum Immunol 66: 717-720, 2005.
25. Hinoda Y, Okayama N, Takano N, Fujimura K, Suehiro Y, Hamanaka Y, Hazama S, Kitamura Y, Kamatani N and Oka M: Association of functional polymorphisms of matrix metalloproteinase-1 (MMP-1) and MMP-3 genes with colorectal cancer. Int J Cancer 102: 526-529, 2002.
26. Tu HF, Liu CJ, Chang CS, Lui MT, Kao SY, Chang CP and Liu TY: The functional -1171 (5A/6A) polymorphisms of matrix metalloproteinase 3 gene as a risk factor for oral submucous fibrosis among male areca users. Oral Pathol Med 35: 99-103, 2006.
27. Su L, Zhou W, Asomaning K, Lin X, Wain JC, Lynch TJ, Liu G and Christiani DC: Genotypes and haplotypes of matrix metalloproteinase 1, 3 and 12 genes and the risk of lung cancer Carcinogenesis 27: 1024-1029, 2006.
28. Yoon S, Tromb G, Vongpunsawad S, Ronkainen A, Juvonen T and Kuivaniemi H: Genetic analysis of MMP3 and MMP9 and PAI-1 in Finnish patients with abdominal aortic or intracranial aneurysms. Biochem Biophys Res Communic 265: 563-568, 1999.
29. Biondi ML, Turri O, Leviti S, Seminati R, Cecchini F, Bernini M, Ghilardi G and Guagnellini E: MMP1 and MMP3 polymorphisms in promoter regions and cancer. Clin Chem 46: 2023-2024, 2000.
30. Kusukawa J, Sasaguri Y, Mormatsu M and Kameyama T: Expression of matrix metalloproteinase-3 in stage I and II squamous cell carcinoma of the oral cavity. J Oral Maxillofac Surg 53: 530-534, 1995.
31. McCawley L, Crawford H, King L, Mudgett J and Matrisian L: A protective role for matrix metalloproteinase-3 in squamous cell carcinoma. Cancer Res 64: 6965-6972, 2004.
32. Kurahara S, Shinohara M, Ikebe T, Nakamura S, Beppu M, Hiraki A, Takeuchi H and Shirasuna K: Expression of MMPS, MT-MMP, and TIMPs in squamous cell carcinoma of the oral cavity: correlations with tumor invasion and metastasis. Head Neck 21: 627-638, 1999.
33. Nagata M, Fujita H, Ida H, Hoshina H, Inoue T, Seki Y, Ohnishi M, Ohyama T, Shingaki S, Kaji M, Saku T and Takagi R: Identification of potential biomarkers of lymph node metastasis in oral squamous cell carcinoma by cDNA microarray analysis. Int J Cancer 106: 683-689, 2003.
34. Kusukawa J ,Harada H, Shima I, Sasaguri Y, Kameyama T and Mormatsu M: The significance of the epidermal growth factor receptor and matrix metalloproteinase -3 in squamous cell carcinoma of the oral cavity. Eur J Cancer B Oral Oncol 32: 217-221, 1996.
35. Yin L, Morita A and Tsuji T: Alterations of extracellular matrix induced by tobacco smoke extract. Arch Dermatol Res 292: 188-194, 2000.
36. Vairaktaris E, Yapijakis C, Derka S, Serefoglou Z, Vassiliou S, Nkenke E, Ragos V, Vylliotis A, Spyridonidou S, Tsigris C, Yannopoulos A, Tesseromatis C, Neukam FW and Patsouris E: Minor association of matrix metalloproteinase-1 (-1607 1G/2G) polymorphism with increased risk for oral squamous cell carcinoma. Anticancer Res 27: 459-464, 2006.
37. Zinzindohoue F, Blons H, Hans S, Loriot MA, Houllier AM, Brasnu D, Laccourreye O, Tregouet DA, Stucker I and Laurent-Puig P: Single nucleotide polymorphisms in MMP1 and MMP3 gene promoters as risk factor in head and neck squamous cell carcinoma. Anticancer Res 24: 2021-2026, 2004.
38. Pendas AM, Matilla T Estivill X and Lopez-Otin C: The human collagenase-3 (CLG3) gene is located on chromosome 11q22.3 clustered to other members of the matrix metalloproteinase gene family. Genomics 26: 615-618, 1995.
39. Hinoda Y, Okayama N, Takano N, Fujimura K, Suehiro Y, Hamanaka Y, Hazama S, Kitamura Y, Kamatani N and Oka M: Association of functional polymorphisms of matrix metalloproteinase (MMP)-1 and MMP-3 genes with colorectal cancer. Int J Cancer 102: 526-529, 2002.